Keyphrases
First-trimester Screening
100%
Fetus
64%
Trisomy 21
63%
Denmark
61%
Nuchal Translucency
57%
Pregnancy-associated Plasma protein-A (PAPP-A)
49%
Pregnant Women
48%
Down Syndrome
42%
Gestational Age
36%
Prenatal Diagnosis
36%
Fetal Medicine
35%
Detection Rate
34%
First Trimester
31%
Chromosomal Abnormalities
28%
Increased nuchal Translucency
25%
Prenatal Screening
25%
Screening Program
23%
Trisomy 13
22%
Array Comparative Genomic Hybridization (aCGH)
22%
Screening for Trisomy 21
22%
Multiple of the Median
22%
Trisomy 18
21%
False Positive Rate
21%
Second Trimester
21%
Live Birth
21%
Prenatal Diagnostics
20%
Normal Karyotype
20%
Biochemical Markers
19%
Gestational Week
19%
Aarhus
19%
Maternal Age
18%
Kidney Disease
18%
Aneuploidy
18%
High Risk
15%
Malformation
15%
Medicine and Dentistry
First Trimester Pregnancy
99%
Nuchal Translucency Measurement
47%
Gestational Age
41%
Trisomy 21
39%
Down Syndrome
36%
Prenatal Diagnosis
34%
Pregnancy
31%
Second Trimester Pregnancy
31%
Chromosome Aberration
31%
Perinatology
30%
Congenital Malformation
28%
Pregnancy-Associated Plasma Protein A
24%
Screening
20%
Twin Pregnancy
18%
Kidney Malformation
18%
Karyotype
16%
Spontaneous Abortion
16%
Color Doppler Flowmetry
16%
Prenatal Screening
15%
